BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Clinical & Diagnostic

Thermo Fisher Launches MagMAX™ Sequential DNA/RNA Kit to Simplify Genomic Analysis for Blood Cancer Research

Thermo Fisher Scientific has introduced the Applied Biosystems™ MagMAX™ Sequential DNA/RNA kit to enable clinical and translational researchers...

December 18, 2024 | News

Nona Biosciences and Candid Therapeutics Collaborate to Advance Next-Generation T-Cell Engagers for Autoimmune Diseases

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), announced a research collaboration and lic...

December 17, 2024 | News

Everest Medicines Announces First Prescription of VELSIPITY® for Ulcerative Colitis in Macau, Marking a Key Milestone in Asia

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...

December 13, 2024 | News

GNT Pharma Announces Promising Nelonemdaz Results, Initiates Global Phase 3 Stroke Trials

** IND submitted to the FDA showing significantly improved patient condition when administered within 70 minutes of arrival at the Emergency Room ** *Mult...

December 12, 2024 | News

GHIT Fund and WHO Strengthen Partnership to Combat Neglected Tropical Diseases

The Global Health Innovative Technology (GHIT) Fund and the World Health Organization (WHO) have signed a memorandum of understanding (MoU) to furthe...

December 11, 2024 | News

Terumo and Medis Partner to Advance Cardiovascular Care

Collaboration combines Terumo's ePRISM™ precision medicine software platform with Medis' QFR® technology – Terumo Health Ou...

December 11, 2024 | News

Actinogen Expands Alzheimer’s Trial Across Australia and US, Eyes Interim Results in 2025

Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026 Appoints US-based Chief Commercial Officer, Andrew Udell X...

December 10, 2024 | News

myTomorrows Expands to APAC with New India Hub to Transform Access to Pre-Approval Treatments

Drawing on its extensive experience connecting physicians and patients to different treatment options, myTomorrows will address challenges in accessing tre...

December 09, 2024 | News

Hansa Biopharma Completes Phase 3 Trial Enrollment Ahead of Schedule for Rare Autoimmune Disease

Hansa Biopharma, "Hansa" announced it has completed the enrolment of patients in the GOOD-IDES-02 trial, a global pivotal Phase 3 trial in anti-glomerular ...

December 06, 2024 | News

NTC Announces Positive Phase II Results for NTC014 in Bacterial Conjunctivitis Treatment

NTC, an international R&D focused pharmaceutical company headquartered in Italy, presents positive results from Phase II MIRAKLE study, a mul...

December 06, 2024 | News

Thermo Fisher Enhances Cell Therapy Manufacturing with CTS Detachable Dynabeads™ for CD4+ and CD8+ T Cell Isolation

T cell isolation and controlled release delivers flexibility and control in process development, clinical trials and commercial manufacturing Thermo Fishe...

December 05, 2024 | News

Biogénesis Bagó Strengthens Asian Presence with New Vietnam Office and FMD Vaccine Rollout

After years of commitment to animal health in the Asian market providing high-quality biotechnological solutions, this significant milestone further streng...

December 04, 2024 | News

Innovent and HUTCHMED Secure Conditional Approval in China for TYVYT® and ELUNATE® Combo in Advanced Endometrial Cancer

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...

December 04, 2024 | News

Everest Medicines Reports Promising Phase 1b/2a Results for EVER001 in Primary Membranous Nephropathy

Patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical remission and 10 out of 11 (91%) ...

December 04, 2024 | News

Stay Connected